More about
Severe Hyperkalemia
News
August 12, 2024
2 min read
Save
GLP-1 use tied to lower risk for hyperkalemia than DPP-IV therapy in type 2 diabetes
Adults with type 2 diabetes using a GLP-1 receptor agonist are less likely to develop hyperkalemia than those using a DPP-IV inhibitor, according to a study published in JAMA Internal Medicine.